Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.31
Price to sales ratio
46.41

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3623
ACOG
Alpha Cognition Inc. - Common Stock
9.16 USD-5.95%-5.76%+3.97%+9.96%199.49 M USD
3625
NKTX
Nkarta, Inc. - Common Stock
2.76 USD+0.36%+5.34%+28.97%+28.37%197.68 M USD
3652
SLGL
Sol-Gel Technologies Ltd. - Ordinary Shares
68.81 USD-5.18%-10.62%-17.31%+187.43%191.72 M USD
3656
KRRO
Korro Bio, Inc. - Common Stock
12.91 USD-2.64%-2.05%+25.83%-66.81%190.11 M USD

Frequently asked questions about Armata Pharmaceuticals, Inc. Common Stock

What is the Armata Pharmaceuticals, Inc. Common Stock stock price today?

The current price of Armata Pharmaceuticals, Inc. Common Stock (ARMP) is 5.30. Over the past 24 hours, the stock has changed by -1.49%. Follow the ARMP chart for real-time price dynamics.

What is the stock ticker of Armata Pharmaceuticals, Inc. Common Stock?

Armata Pharmaceuticals, Inc. Common Stock trades under the ticker ARMP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Armata Pharmaceuticals, Inc. Common Stock stock going up?

ARMP has changed by +6.43% over the last week, +15.72% over the last month, and -35.15% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Armata Pharmaceuticals, Inc. Common Stock?

Armata Pharmaceuticals, Inc. Common Stock currently has a market capitalization of 197.06 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Armata Pharmaceuticals, Inc. Common Stock earnings last quarter?

Last quarter, Armata Pharmaceuticals, Inc. Common Stock reported earnings of 2.02 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Armata Pharmaceuticals, Inc. Common Stock revenue for the last quarter?

Armata Pharmaceuticals, Inc. Common Stock reported quarterly revenue of 2.51 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Armata Pharmaceuticals, Inc. Common Stock net income for the last quarter?

Armata Pharmaceuticals, Inc. Common Stock reported net income of 74.14 M for the last quarter. The previous quarter showed -115.35 M, which means net income changed by +164.28%.

How many employees does Armata Pharmaceuticals, Inc. Common Stock have?

As of the latest available data, Armata Pharmaceuticals, Inc. Common Stock has 61 employees. Workforce size can provide additional context about the company's scale and operations.

What is Armata Pharmaceuticals, Inc. Common Stock EBITDA?

Armata Pharmaceuticals, Inc. Common Stock EBITDA is -9.81 M, and its EBITDA margin is -390.92%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Armata Pharmaceuticals, Inc. Common Stock stock?

You can buy Armata Pharmaceuticals, Inc. Common Stock (ARMP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Armata Pharmaceuticals, Inc. Common Stock stock?

Investing in Armata Pharmaceuticals, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ARMP chart and related analysis on metatrader.com as part of your research.

News